tiprankstipranks
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
PremiumPress ReleasesPAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
23d ago
ResMed announces PAP therapy reduces hospitalizations by 31%, ER visits by 23%
PremiumThe Fly
ResMed announces PAP therapy reduces hospitalizations by 31%, ER visits by 23%
23d ago
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
PremiumPress Releases
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
1M ago
Early notable gainers among liquid option names on April 26th
PremiumThe FlyEarly notable gainers among liquid option names on April 26th
2M ago
ResMed price target lowered to $200 from $205 at Oppenheimer
PremiumThe Fly
ResMed price target lowered to $200 from $205 at Oppenheimer
2M ago
ResMed price target raised to $236 from $224 at Needham
PremiumThe Fly
ResMed price target raised to $236 from $224 at Needham
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100